L-Arginine Metabolism in Essential Hypertension

Clinical trial NCT00137124 · COMPLETED

Trial details

NCT number: NCT00137124
Sponsor: University of Erlangen-Nürnberg Medical School
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2006-05-01
Primary completion: 2009-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.